Cancer Genetics Q4 Revenues Improve 73 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics said after the close of the market on Wednesday that its fourth quarter revenues increased 73 percent year over year.

For the three months ended Dec. 31, 2013 the Rutherford, NJ-based cancer diagnostics firm reported revenues of $1.9 million, up from $1.1 million in the year-ago quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.